TIME reports on evidence along the Thai-Cambodia border that the malaria parasite is gaining resistance to artemisinin â€“ “the only remaining effective drug in the world’s arsenal against malaria’s most deadly strain.”
The June issue of the Global Fund to Fight AIDS, Tuberculosis and Malaria’s email newsletter, the “Global Fund News Flash,” was released on Thursday. The issue highlights the Global Fund’s “Better Grants for Increased Impact” project, discusses malaria in Madagascar, notes the launch of the (RED) RUSH TO ZERO campaign, profiles Indonesia Fund Portfolio Manager Gail Steckley, and features a new cell phone application from Charity Miles, which “enables people to earn money for charity simply by walking, running or biking” (6/7).
During a live webcast discussing recent changes at the Global Fund to Fight AIDS, Tuberculosis and Malaria, “[p]anelists discussed the fund’s new strategy and what this strategy means for the global fight against these three diseases,” GlobalPost’s “Global Pulse” blog reports. J. Stephen Morrison, senior vice president and director of the Global Health Policy Center at the Center for Strategic and International Studies, noted the Global Fund’s new general manager, Gabriel Jaramillo, had moved quickly in focusing on restructuring and realigning the fund, according to the blog. Todd Summers, independent consultant and chair of the Strategy, Investment & Impact Committee at the Global Fund, said, “Now we see lots of opportunity to really make a big difference and change forever the trajectory” of the epidemics, “Global Pulse” notes.
The Affordable Medicines Facility-malaria (AMFm) — an innovative financing mechanism that subsidizes the cost of artemisinin-based combination therapies (ACTs) in order to expand access to the most effective treatment for malaria — “brought more than 100 million doses of malaria drugs to clinics and pharmacies in 2011” and “also increased access to the top malaria medicines by 26 to 52 percent in six countries,” according to results from the first phase of the program, which is hosted and managed by the Global Fund to Fight AIDS, Tuberculosis and Malaria, NPR’s “Shots” blog reports. The results of the evaluation, released on Wednesday in Washington, D.C., do not estimate how many lives were saved because of improved access to effective malaria medications, as “AMFm ran for only a year and half in most countries,” according to the blog. “The AMFm negotiated with drugmakers to reduce ACTs prices, and then the Global Fund subsidized the initial purchasing of the drugs by clinics and pharmacies,” the blog notes.
Devex News Analysis Examines Democratic, Republican Party Platforms On Foreign Policy, Including Global Health
A Devex news analysis examines the Democratic and Republican platform positions on foreign policy following the party conventions, writing, “Even as pocketbook concerns continue to overshadow foreign policy issues on the campaign trail, in both Charlotte and Tampa, top-billed speakers made the case for the U.S. foreign aid program.” The article examines the core principles of each platform, notes that neither platform offers specifics on foreign aid spending, and discusses the platforms’ stances on certain foreign policy issues, including global health, food security, climate change, and gay rights.
Developing Countries NGO Delegation To Global Fund Submits Report Highlighting Challenges, Recommendations
The Center for Global Health Policy’s “Science Speaks” blog discusses a report by the developing countries NGO delegation to the Global Fund to Fight AIDS, Tuberculosis and Malaria, submitted recently to the Global Fund Secretariat. “Covering procedures involved in program planning, spending, accounting and in responding to realities on the ground, some of the issues it raises are likely to be addressed in the global charity’s new funding model, but some may not be, a delegation representative wrote in response to an inquiry from ‘Science Speaks,’” the blog notes and highlights some of the challenges and recommendations contained in the report (Barton, 9/4).
PlusNews examines the recently approved grants under the Global Fund to Fight AIDS, Tuberculosis and Malaria’s Transitional Funding Mechanism (TFM), stating, “Last week, the Fund announced that 45 new grant applications, from countries such as Burundi, Malawi and Swaziland, have been approved under the TFM.” The news service notes, “Almost 25 percent of this combined total will go towards [tuberculosis (TB)], which represents a significant increase from the average 16 percent of funds allocated for TB since the Global Fund was created in 2002, according to a StopTB Partnership statement released in response” to the fund’s announcement. PlusNews notes, “Unlike regular grants, which can run for up to five years, those awarded under the TFM will be limited to two years, by which time the fund is expected to have launched its new funding model” (9/4).
The Coca-Cola Company and the Global Fund to Fight AIDS, Tuberculosis and Malaria have announced the expansion of a pilot project, called “Project Last Mile,” that uses Coca Cola’s “‘expansive global distribution system and core business expertise’ to help deliver critical medicines to remote parts of the world, beginning in rural Africa,” Pharma Times reports. “The public-private partnership was established in 2010 to help Tanzania’s government-run medicine distribution network, Medical Stores Department, build a more efficient supply chain by using Coca-Cola’s” delivery system model, the news service writes, adding, “The latest phase of the partnership, developed in cooperation with the likes of the Bill & Melinda Gates Foundation, Accenture and Yale University, will increase the availability of critical medicines to 75 percent of Tanzania and expand the initiative to Ghana and Mozambique” (Grogan, 9/26).
“The Global Fund to Fight AIDS, Tuberculosis and Malaria has released initial details on its new funding model, … [b]ut as the fund works to finalize the model before next year, civil society is criticizing the process for being untransparent and rushed,” IRIN reports in an article examining the draft model and reaction to it. Some groups have expressed concern over the fund’s decision to “base funding allocations for each diseases on previously used levels for up to one year,” while “many African civil society organizations have expressed dissatisfaction with the speed and transparency of the process,” IRIN writes. “The Global Fund board is expected to make a final decision on the model at its November board meeting,” the news service notes (9/25).
Secretary of State Hillary Clinton reflects on changes in U.S. global health diplomacy since taking office in this Global Health and Diplomacy opinion piece. “America had been leading the global health fight for decades,” but “we recognized that to sustain the impact of our work, we needed to change the way we did business,” she writes. “For example, while our agencies were providing tremendous leadership in isolation, they could still do more to collaborate effectively,” she writes, adding, “[W]e weren’t doing enough to coordinate our efforts with other donors or our partner countries,” and “we weren’t building sustainable systems to eventually allow our partner countries to manage more of their own health needs.” She says, “We were unintentionally putting a ceiling on the number of lives we could save.”